• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LP LLC NORTH HAVEN SURGIPRO; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LP LLC NORTH HAVEN SURGIPRO; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number UNKNOWN SURGIPRO MESH
Device Problems Degraded (1153); Migration or Expulsion of Device (1395); Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problems Abdominal Pain (1685); Abscess (1690); Adhesion(s) (1695); Bacterial Infection (1735); Erosion (1750); Emotional Changes (1831); Fistula (1862); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Inflammation (1932); Nausea (1970); Pain (1994); Hernia (2240); Anxiety (2328); Distress (2329); Depression (2361); Impaired Healing (2378); Hematuria (2558); Fluid Discharge (2686); Thrombosis/Thrombus (4440); Sexual Dysfunction (4510); Unspecified Tissue Injury (4559); Decreased Appetite (4569); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for a laparoscopic therapeutic treatment of a left inguinal hernia.It was reported that after the implant, the patient experienced recurrence, adhesions, infection, mesh erosion, hematuria, fistula, abscess, mesh migration, damage to the bladder, and pain and suffering.Post-operative patient treatment included mesh removal surgery, and revision surgery.
 
Manufacturer Narrative
Additional information: b5, d3(mfr name, street 1, mfr region, country code, postal code), d6b, g3, h6 medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for a laparoscopic therapeutic treatment of a left inguinal hernia.It was reported that after the implant, the patient experienced inflammation, bacterial infection, mesh degradation, mesh not properly incorporated in tissue, chronic draining abscess, bladder lesion, mesh extrusion, draining wound, large bladder stone, nausea, loss of appetite, stress/anxiety, defective device, mental and physical pain, injury, disability, loss of enjoyment of life, recurrence, adhesions, infection, mesh erosion, hematuria, fistula, abscess, mesh migration, damage to the bladder, and pain and suffering.Post-operative patient treatment included mesh removal surgery, hernia repair, lysis of adhesions, cystoscopy, placement of new mesh, drainage of abscess, and revision surgery.
 
Manufacturer Narrative
Additional info: a4, b5, b7, d6b, h6 (patient codes, imf code, ime e2402: "loss of appetite, bladder lesions, large bladder stone, t hickened bladder wall").Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for a laparoscopic therapeutic treatment of a left inguinal hernia.It was reported that after the implant, the patient experienced bleeding, blood with ejaculation, bladder defect, blood clots, thickened bladder wall, abdominal pain, poor sex life, blood in urine and sperm, depression, inflammation, bacterial infection, mesh degradation, mesh not properly incorporated in tissue, chronic draining abscess, bladder lesion, mesh extrusion, draining wound, large bladder stone, nausea, loss of appetite, stress/anxiety, defective device, mental and physical pain, injury, disability, loss of enjoyment of life, recurrence, adhesions, infection, mesh erosion, hematuria, fistula, abscess, mesh migration, damage to the bladder, and pain and suffering.Post-operative patient treatment included mesh removal surgery, hernia repair, lysis of adhesions, cystoscopy, placement of new mesh, drainage of abscess, and revision surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGIPRO
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
COVIDIEN LP LLC NORTH HAVEN
195 mcdermott rd
north haven CT 06473
Manufacturer (Section G)
COVIDIEN LP LLC NORTH HAVEN
195 mcdermott rd
north haven CT 06473
Manufacturer Contact
justin ellis
5920 longbow drive
8200 coral sea st ne
mounds view,mn, CO 55112
7635265677
MDR Report Key12112123
MDR Text Key260214645
Report Number9615742-2021-01651
Device Sequence Number1
Product Code FTL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 06/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN SURGIPRO MESH
Device Catalogue NumberUNKNOWN SURGIPRO MESH
Device Lot NumberAOB254
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/16/2021
Initial Date FDA Received07/02/2021
Supplement Dates Manufacturer Received10/27/2021
06/19/2024
Supplement Dates FDA Received11/15/2021
06/25/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
Patient SexMale
Patient Weight78 KG
-
-